endocrinology

Orthopaedic surgeon attitudes a barrier to bisphosphonate use after fragility fractures

Orthopaedic surgeons appear reluctant to initiate early bisphosphonate therapy following fragility fractures due to misperceptions about bone healing, a Victorian study suggests. According to a retrospective audit of practice at Boxhill Hospital, only 32 (18%) of 181 patients with fragility fractures likely to be due to osteoporosis were started on bisphosphonates. A survey of orthopaedic ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic